19 results on '"Xu, Zi-Zhen"'
Search Results
2. Lithium-ion Migration in Layered Li1.06Ni0.5Co0.2Mn0.3O2 Cathode Materials Synthesized at Different Temperatures
3. Fabrication of a Gradient Nano-/Micro-structured Surface Layer on an Al–Si Casting Alloy by Means of Ultrasonic–Electropulsing Coupling Rolling Process
4. Serum BAFF and APRIL levels in patients with autoimmune hemolytic anemia and their clinical significance
5. Activation of the PI3K/AKT/mTOR pathway in diffuse large B cell lymphoma: clinical significance and inhibitory effect of rituximab
6. The prognostic value of immunohistochemical subtyping in Chinese patients with de novo diffuse large B-cell lymphoma undergoing CHOP or R-CHOP treatment
7. Summary of 615 patients of chronic myeloid leukemia in Shanghai from 2001 to 2006
8. Enhanced Surface Mechanical Properties of Cr12MoV Using Ultrasonic Surface Rolling Process and Deep Cryogenic Treatment
9. Clinical significance of chemokine receptor CXCR4 and mammalian target of rapamycin (mTOR) expression in patients with diffuse large B-cell lymphoma
10. HSP70-Hrd1 axis precludes the oncorepressor potential of N-terminal misfolded Blimp-1s in lymphoma cells
11. Reactive oxygen species mediate oridonin-induced apoptosis through DNA damage response and activation of JNK pathway in diffuse large B cell lymphoma
12. Clinical significance of chemokine receptor CXCR4 and mammalian target of rapamycin (mTOR) expression in patients with diffuse large B-cell lymphoma.
13. Combination of rituximab and mammalian target of rapamycin inhibitor everolimus (RAD001) in diffuse large B-cell lymphoma
14. Reactive oxygen species mediate oridonin-induced apoptosis through DNA damage response and activation of JNK pathway in diffuse large B cell lymphoma.
15. Summary of 615 patients of chronic myeloid leukemia in Shanghai from 2001 to 2006
16. Activation of PI3K/Akt/mTOR Pathway in Diffuse Large B-Cell Lymphomas: Clinical Significance and Inhibitory Effect by Rituximab.
17. The prognostic value of immunohistochemical subtyping in Chinese patients with de novo diffuse large B-cell lymphoma undergoing CHOP or R-CHOP treatment
18. Combination of rituximab and mammalian target of rapamycin inhibitor everolimus (RAD001) in diffuse large B-cell lymphoma.
19. BAFF level increased in patients with autoimmune hemolytic anemia.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.